Bob Repella was Appointed as Chief Executive Officer at Harmony-Biosciences

Date of management change: October 15, 2016 

What Happened?

Plymouth Meeting, PA-based Harmony-Biosciences Appointed Bob Repella as Chief Executive Officer

 

About the Company

atients are at the beginning, middle, and heart of all we do. Harmony Biosciences is an innovative biopharmaceutical company dedicated to identifying, developing, and commercializing novel treatment options for patients with rare diseases. With an emphasis on central nervous system disorders, our goal is to push the boundaries of what science can do to improve the lives of patients. Our primary mission is to have a positive impact on the lives of those who are so often underserved. We believe it takes both scientific vision and tenacity to pursue new therapies that will have the potential to transform the lives of patients. We are proud to be partnering with Dr. Jeanne-Marie Lecomte and Prof. Jean-Charles Schwartz, co-founders of French company Bioprojet SCR (Bioprojet), to develop, register, and market a selective histamine H3-receptor antagonist/inverse agonist for the potential treatment of adult narcolepsy. Currently, no H3-receptor antagonist/inverse agonist has been approved by the US Food & Drug Administration. We believe there is tremendous potential in this receptor and we are both proud and excited to be a part of the prospective novel treatments it might offer.

 

About the Person

Bob Repella is Chief Executive Officer at Harmony Biosciences. Previously, Bob held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Howard Kim, Sood Nishu, Kirksey Jennifer, Wesloskie Kathleen, Bean Percy, Cerf Christopher, Castle Dedra, Timmons Marie, Traywick Gale, Musson Susan, Rivera Brenda

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.